Endothelins (ETs) are a family of 21 amino acid peptides with diverse biological actions [1±5]. Alteration of ETs are of importance in several vascular dysfunctions [1±6]. ETs are produced by endothelium and other non-vascular cells [3, 6] . In the rat retina both . Others and we have previously shown that in the retina, ET-1 and ET-3 are present in the endothelium but not in the pericytes, as well as in the non-vascular cells such as Müller cells and ganglion cells [7±9]. We have also shown that in the retina of the long-term diabetic BB-rats, immunoreactivity and mRNA expression for both ET-1 and ET-3 as well as ET A and ET B receptor mRNA expressions were increased [7, 10] .
through a variety of mechanisms [11±15] . Protein kinase C (PKC), which is activated in the retina in diabetes, is a known up regulator of ET-1 and causes ET receptor induction [1±5, 14, 15] . ET-1, in turn, stimulates diacylglycerol (DAG) activity which further activates PKC [1±5] . In the aorta ET-1 has been shown to stimulate Na + -K + -ATPase activity by a PKC dependent pathway [16] . In kidneys from diabetic animals increased ET-1 synthesis and down regulation of ET receptors can be prevented by PKC inhibitors [17] .
Short-term vasoactive properties of ET-1 up regulation could lead to vasoconstriction and alterations in blood flow in the retina and peripheral nerve in diabetes [18±20] . ETs might, however, also affect gene expression of other vasoactive substances such as vascular endothelial growth factor (VEGF), nitric oxide (NO) synthase and structural proteins [1±5, 21] . Nitric oxide inhibits the production and action of ET-1. On the other hand, ET-1 stimulates the production of NO [1±5] . In cultured endothelial cells a stimulatory interaction among ET-1, ET-3 and VEGF has been shown [21, 22] . In the kidneys of diabetic rats ET-1 inhibition results in reduced mRNA expression of extracellular matrix proteins [23] .
To improve our understanding of the role of ETs in the retina in diabetes, we investigated diabetes-induced alteration of blood flow in the rat retina and studied the effects of the blockade of ET A and ET B receptors after short-and long±term follow-up. In addition, we investigated ET-1, ET-3, ET A and ET B with respect to their distribution and mRNA expression in the retina.
Subjects and methods
All animals were cared for in accordance with the Declaration of Helsinki regarding the guiding principles in the care and use of animals. The University of Western Ontario council on animal care committee formally approved all experimental protocols. Male Sprague-Dawley rats weighing approximately 200 g were obtained from Charles River Canada Ltd. (St. Constant, PQ, Canada). Diabetes was induced by a single intravenous injection of streptozotocin (STZ, 65 mg/kg of body weight, in citrate buffer). Age-and sex-matched non-diabetic control animals received an injection of the same volume of citrate buffer. Diabetic rats were randomized into a) a poorly controlled diabetic group and b) a poorly controlled diabetic group on bosentan treatment. Bosentan, a potent ET A and ET B receptors blocker, was obtained from Hoffman-La-Roche (courtesy of Dr. M. Clozel) and was given by daily oral gavage (100 mg/kg of body weight/day) [24] . The animals were given rat chow and water ad libitum. They were monitored daily with respect to body weight, urine glucose, urine sugar and ketones. Diabetic animals received small daily doses (0.1±3.0 U) of ultra lente insulin (Novo Nordisk, Princeton, N. J. USA). Before killing the animals they were anaesthetized with methoxyflurane inhalation (Mallinckrodt Veterinary Inc. Mundelein, Ill., USA) and laser Doppler analysis of retinal blood flow of the right eye was done. Following death, the retina of the right eye of each animal was snap frozen in liquid nitrogen. The left eyes were fixed in 10 % buffered formalin for histological analysis. Blood was collected and analysed for glucose (Sure step, Lifescan, Burnby, BC, Canada) and glycated haemoglobin levels (Glycotest , Pierce, Rockford, Ill., USA). All investigations were done in a masked fashion.
Blood flow analysis. Following anaesthesia, the central retinal vasculature was localized with a 8L5 8.0MHZ probe for colour Doppler sonography (Acuson Sequoia 2.5, Mountainview, Calif., USA) and Doppler waveforms were examined [25] . Several trial recordings were carried out to optimize the sensitivity at an acceptable noise level. The colour Doppler showed blood flow towards the transducer in red, and blood flow away from the transducer in blue. Colour images were obtained in real time and Doppler spectral analyses were done. From the recordings of the arterial blood flow, using peak systolic velocity (SV) and end diastolic velocity (DV), resistivity indices (RI) were calculated as (SV-DV)/SV (Fig. 1) . At least three measurements from each recording were carried out and the mean of the three readings was taken as the representative. An increase in the RI in the central retinal artey is indicative of increased resistance in the distal vascular bed, i.e, vasoconstriction at the precapillary or at the capillary level in the retina [25] .
RNA isolation. TRIZOL reagent (Canadian Life Technologies Inc. Burlington, ON, Canada) was used to isolate RNA from the retina according to the previously described methodologies [10] . Quantitation of RNA was done by determining the absorbance at 260 nm and 280 nm.
First strand cDNA synthesis. First strand cDNA synthesis was carried out using Superscript-II system (Canadian Life Technologies Inc.) according to the previously described methodologies [10] . The resulting products were stored at ±20°C.
Polymerase Chain Reaction (PCR).
The amplification was carried out using the following of our previously described methodologies with some modifications [10] .
For ET-1, primer 1 (sense, 5'-GCTCCTGCTCCTCCTT-GATG-3') and primer 2 (antisense, 5'-CTCGCTCTATG-TAAGTCATGG-3') with a predicted product size of 499 bp and for ET-3, primer 1 (sense, 5'-GCACTTGCTTCACTTA-TAAGG-3') and primer 2 (antisense 5'-ACAGAAGCA-AGAAGCATCAGTTG-3') with a predicted product size of 383 bp were used [26] . For ET A primer 1 (antisense, 5'-TTCGTCATGGTACCCTTCGA-3') and primer 2 (sense 5'-GATACTCGTTCCATTCATGG-3') with a predicted product size of 546 bp and for ET B primer 1 (antisense 5'-TTCACCT-CAGCAGGATTCTG-3') and primer 2 (5'-AGGTGTGGA-AAGTTAGAACG-3') with a predicted product size of 475 bp were used [26] .
Reactions were carried out in 30-ml volumes containing 1.5 mmol/l MgCl 2 and 4 ml of the RT product and following the cycling parameters as described previously [10] . The linearity of the PCR reaction was established by analysing PCR products with variable amounts of template and variable cycle numbers. It has been previously shown that in this reaction the PCR amplification is log-linear up to 40 cycles [26, 27, 28] . In this study, we used 30 cycles of amplification for ET-1 and ET-3, and 35 cycles for ET A and ET B. Simultaneously a housekeeping gene (b-actin) was amplified in a separate set of tubes using the same RT-product, 5'-TGGTGGTATGGGTCA-GAAGG-3' and 5'-ATCCTGTCAGCGATGCCTGGG ±3' primer sets using the same cycling parameters with a predicted product size of 813 bp [29] . The amplification products were analysed on a 2.5 % agarose gel under ultraviolet light following electrophoresis and ethidium bromide staining.
Southern hybridization. The specificity of the amplifications were confirmed by Southern blot of the PCR products using biotinylated specific internal oligoprobes (ET-1: 5'-CA-AAGACCACAGACCAAGGG-3', ET-3: 5'-CCTGCA-CAGCCTGGAAATGC-3' ET A, : 5'-CGAGGTCATGAGG-CTTTTGG-3' and ET B : 5'-TGCAGACCTTTCCGCAAG-CACG-3', b-actin5'-CTGACCCTGAAGTACCCCATT-3') using previously described methodologies [10, 26±28] . The detection was carried out using a NBT/BCIP system (Sure blot, Oncor, Gaithersburg, Md., USA).
Quantitation. Quantitation was carried out by serial dilution slot-blot hybridization and densitometry of the products from the upstream (following 30 cycles for ET-1 and ET-3, and 35 cycles for ET A and ET B ) of amplification. Hybridizations were carried out using the biotinylated oligoprobes as described above. The blots were analysed by a Hewlett-Packard 4 C scanner and using Mocha software (Jandel Scientific, San Rafael, Calif., USA). The densitometric values were measured as arbitrary units per ug of total RNA and the ratio of b-actin (which did not vary among various groups) to the specific gene(s) was obtained [10] .
Immunoctyochemistry. Five mm thick sections on positively charged slides were used for immunocytochemistry using polyclonal anti-rabbit ET-1 and ET-3 antibodies (Peninsula Laboratories, Belmont, Calif., USA) and a streptavidin-biotin-peroxidase technique (Vector Laboratories, Burlingame, Calif., USA), as previously described by us [7] . The specificity of these antibodies has already been established [7, 8] . Negative controls included non-immune rabbit serum and antibodies preabsorbed with an excess of purified peptides (Peninsula Laboratories).
ET receptor localization. The receptor autoradiography was carried out using paraffin embedded retinal tissues as described previously [30] . Briefly, the sections were deparaffinized and preincubated in PBS containing 0.1 mmol/l phenylmethyl-sulphonyl-fluoride for 30 min. The sections were then incubated for 2 h in 0.12 mmol/l 125 I-ET-1 (NEN Dupont, Mississanga, Canada) in the presence or absence of cold ET-1. The slides were dipped into Kodak NTB-3 emulsion, dried and exposed for 5 days in the dark. The autoradiograms were developed in Kodak D19 developer and counterstained with haematoxylin and eosin.
Statistical analysis. The data are expressed as means ± SEM and were analysed by Student's t test. A p value of less than 0.05 was accepted as being significant.
Results
Diabetic animals with or without bosentan treatment showed reduced body weight gain, hyperglycaemia, glycosuria and increased glycated haemoglobin levels ( Table 1 ). After one month of diabetes the RI, measured by colour Doppler sonography, was significantly (p < 0.05) increased in the diabetic animals compared with the control animals ( Fig. 1 ). This increased RI was corrected by treatment with bosentan. After 6 months of diabetes this alteration of RI was not verifiable in the diabetic animals. The data further show an age-related increase in the RI in the normal rats (Fig. 1) .
Both ET peptides and their receptors were present in the retina of diabetic and non-diabetic rats. Analysis of RNA by semi-quantitative RT-PCR from the linear phase of amplification showed that, after 1 month of diabetes retinal mRNA for ET-1, ET-3 and ET A were significantly (p < 0.03 or less) raised (Fig. 2) . In addition after 6 months of follow-up, ET B mRNA was also significantly (p < 0.007) raised (Fig. 3) . As expected bosentan treatment did not have any effects on any of these mRNA levels (Fig. 2, 3) .
Immunocytochemical analysis showed that, similar to our previously published results [7] , both ET-1 and ET-3 were distributed in the retinal vasculature (endothelial cells), ganglion cells, Müller cells, bipolar cells, photoreceptor outer segment, and retinal pigment epithelium. Both after 1 and 6 months of follow-up an increased ET-1 and ET-3 immunoreactivity was present in the retina of diabetic animals with or without bosentan treatment (data not shown).
Autoradiographic receptor localization as shown by the presence of silver grains showed 125 I-ET-1 binding in all layers of the retina. The localization was stronger on the ganglion cell layers and on the outer and inner nuclear layers. Preincubation with cold ET-1 caused a reduction of the binding to the level of background. In diabetes the binding was increased (Fig. 4) . Retinas from the animals treated with bosentan showed a reduction of the 125 I-ET-1 binding. 
Discussion
In this study we have shown that retinal vasoconstriction in early diabetes was associated with ET-1, ET-3 and ET A mRNA up regulation, increased immunoreactive ET-1 and ET-3 and raised ET receptor concentrations. Diabetes-induced retinal vasoconstriction was prevented by treatment with ET receptor antagonist bosentan. Vasoconstriction was not present after 6 months of diabetes. At this stage ET B receptor mRNA was also upregulated. The RT-PCR based method used in this study allowed us to measure the mRNA expression of multiple genes from a small amount of RNA. This method has previously been used to quantitate gene expression in the retina by us and other investigators [10, 29] . In keeping with the present data, others and we have previously established that several cell types in all segments of the eye showed immunoreactivity for ET-1 and ET-3 with overall increased immunoreactivity in diabetes [7±9]. Furthermore, ET receptors have previously been shown in the vascular and neuronal components of the retina [9, 31] . This study has provided direct evidence linking the ET system to the pathogenesis of vascular dysfunction in the retina in experimental diabetes. We used colour Doppler sonography to detect retinal blood flow in the rats in diabetes. This sensitive, non-invasive technique provided the opportunity to do a realtime recording in the blood vessels of choice. This technique, although it has been used in human diabetic subjects, to our knowledge has not been used previously in diabetic animals [32±34] . The present data showing increased RI in early diabetes suggest a vasoconstriction which was not verifiable in longterm follow-up. This is in keeping with previous studies by other investigators suggesting a vasoconstriction in several organs in early diabetes [14, 15, 19] . On the other hand, some investigators have shown an increased blood flow in multiple organs in diabetes [11] . It is to be pointed out that the RI measured in B Fig. 1 A, B. A Representative colour Doppler sonography from a rat eye showing localization of central retinal artery and vein; the lower pannel shows spectral analysis. Method of resistivity index (RI) measurement is shown in the inset (A = peak systolic velocity, B = end diastolic velocity). B RI from diabetic, bosentan-treated diabetic and non-diabetic control animals after 1 month and after 6 month of follow-up. * = significantly (p < 0.05) different from 1 month non-diabetic controls A Fig. 2 . Semiquantitative mRNA analysis by RT-PCR from the retina of diabetic, bosentan-treated diabetic and non-diabetic control animals after 1 month of follow-up. The data are expressed as the ratio of housekeeping gene b-actin, which did not alter in various groups * = significantly (p < 0.03 or less) different from the controls this study does not indicate actual blood flow [25, 32, 33] . It is possible for the blood flow to increase or decrease depending on the grades of vasoconstriction within a physiologic range. The pattern of blood flow in the central retinal arteries, however, is like that of large arteries with low end diastolic pressure. As there was no local stenosis in any of our animals, increased RI was indicative of distal vasoconstriction, i.e, at the precapillary or at the capillary level [25] . This could have led to a reduction of blood flow in the retinal capillary bed, although the exact volume of blood flow reduction was not known [25, 32±34] . In human diabetes using a similar method, it has been shown that diabetic patients with or without retinopathy compared with non-diabetic subjects have a higher RI [32] . There is much discrepancy between various studies in human and animal diabetes regarding alterations in blood flow as apparent from an indepth review published recently [35] . Nevertheless our study suggests the important part played by the ET system in the generation of this functional abnormality in diabetes. In the peripheral nerve ET-receptor blockade has been shown to improve diabetes-induced reduced nerve conduction velocity and blood flow abnormalities [20] .
The differential expression of ET A and ET B mRNA after 1 and 6 months of follow-up suggests that the components of the ET system might change over time leading to a wide range of effects. Among the ET receptors, ET A binds with ten times higher affinity with ET-1 compared with ET-3. ET B , however, binds with both ET-1 and ET-3 with equal affinity [1±6] . ET A is predominantly responsible for mediating vasoconstricting effects of ET-1 by way of phospholipase C, inositol trisphosphate formation and increase in intracellular Ca ++ [2±5] . On the other hand, it has been shown that binding of ET-3 with ET B receptors might cause vasodilatation mediated by an in- crease in NO and prostaglandin production and activation of K + channels [2±5]. It is possible, that in this study increased ET B production after 6 months might have a balancing effect on ET-1-induced vasoconstriction. Note that after 6 months of diabetes, retinal RI in the non-diabetic animals was significantly (p < 0.05) higher than that in 1 month non-diabetic animals. This change probably reflects the effect of normal ageing processes. In human diabetic subjects time-dependent alteration of ET-1 has been shown in the cutaneous microvessels in which, although ET-1 was increased in short-term diabetes, it was decreased after long-term follow-up [36] .
Apart from vasoconstriction, an altered ET system might have various effects in the retina in diabetes. In the retina, ETs probably play important parts in neurotransmission and neuromodulation [1±9] . Several modulators of ETs, such as protein kinase C (PKC), Ca ++ and nitric oxide (NO) are altered in diabetes [11±15, 37]. Diabetes-induced PKC activation could be responsible for ET up regulation in the retina [1±6, 11, 14, 15, 37] . Other potent vasoactive substances such as NO and prostacyclin interact with ET which in turn possesses a positive feedback regulatory action on NO-synthesis [1±6]. ET-1 and ET-3 have been shown to up regulate VEGF production in endothelial cells [21, 22] . On the other hand VEGF increases ET-1 mRNA and protein expression in the endothelial cells [21, 22] .
It is, however, not clear what impact altered expression of ETs and their receptors possibly have on the development of diabetic retinal lesions in the long-term. It has been postulated that loss of contractile function of pericytes in diabetes might be related to changes in ET-1 [38] . The long-term consequences of an augmented ET system possibly further contribute to long-term nuclear signalling and involve cellular changes secondary to altered gene expression [1±6, 39] . Increased extracellular matrix protein synthesis and subsequent structural changes such as basement membrane thickening are hallmarks of diabetic retinal microangiopathy [11, 12, 15] . It has been shown that diabetes-induced up regulation of glomerular a1(I), a1(III), a1(IV) collagen, laminin B1 and B2, tumour necrosis factor a, platelet derived growth factor, transforming growth factor b, and basic fibroblast growth factor genes can be completely blocked by treatment with an ET A receptor antagonist [23] . It is possible that, similar to kidneys in diabetic rats, ETs influence gene expression of extracellular matrix proteins in the retina leading to the development of structural changes [1±6, 23, 39] .
